CleveMed’s NeuroSense line is undergoing testing in the U.S. and Europe and is awaiting clearance for sale in both locations, according to the report. It is still developing its seizure detection products.
Read the Crain’s report about CleveMed’s license agreement with NeuroWave.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
